SynthesisJournal of comparative effectiveness research2026

Evaluating amyloid-beta as a surrogate endpoint in trials of anti-amyloid-beta drugs in Alzheimer's disease: a Bayesian meta-analysis.

Sa Ren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.